Jim Simons Vaxart, Inc. Call Options Transaction History
Renaissance Technologies LLC
- $70.6 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding VXRT
# of Institutions
64Shares Held
9.56MCall Options Held
66.1KPut Options Held
0-
Black Rock Inc. New York, NY1.77MShares$656,5080.0% of portfolio
-
Marshall Wace, LLP London, X01.76MShares$652,6360.0% of portfolio
-
State Street Corp Boston, MA851KShares$314,9140.0% of portfolio
-
Ubs Group Ag826KShares$305,5300.0% of portfolio
-
Squarepoint Ops LLC New York, NY447KShares$165,3350.0% of portfolio
About Vaxart, Inc.
- Ticker VXRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 126,506,000
- Market Cap $46.8M
- Description
- Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...